Study brings insight to kidney cancer with gene mutation

Researchers studied over 800 clinical assays of renal cancer with a specific genetic mutation, the largest series of its kind

5:00 AM

Author | Anna Megdell

gloved hand doing microplate samples
Getty Images

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology and the Michigan Center for Translational Pathology reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

The study, published in the American Journal of Clinical Pathology¸ is the largest series of its kind in kidney cancer and carries deep clinical and diagnostics implications.

The team, led by Rohit Mehra, M.D., performed over 800 clinical assays on the MiTF family genes TFE3 and TFEB in renal tumors with morphologic and biomarker alterations considered suspicious for MiTF family genetic mutations.

The findings show that the patients who had renal tumors with TFEB amplification were significantly older than patients with renal tumors housing TFE3 or TFEB translocation.

Further, renal tumors with TFEB amplification, known to be associated with poor prognosis, were seen to be at least three times as common as those with TFEB translocation.

Mehra says these assays are the gold standard for diagnosing MiTF mutated renal cell carcinoma.

“These findings give us a comprehensive picture of the molecular landscape of renal tumors with MiTF family aberrations,” said Mehra.

“Renal cell carcinoma prognosis and personalized therapy can be heavily influenced by renal tumor subtyping, and these FISH assays are crucial towards identifying such genomic aberrations.”

These assays help accurately categorize patients with the MiTF mutation into three genomic categories: TFE3 translocation, TFEB translocation and TFEB amplification.

This knowledge adds further understanding to the complexities in kidney cancer disease, and can help provide researchers and clinical teams with deeper diagnostic, prognostic and clinical insight.

Additional authors include Xiao-Ming Wang, Ph.D., Lina Shao, M.D., Ph.D., Hong Xiao, Ph.D., Jeffrey L Myers, M.D., Liron Pantanowitz, M.D., Stephanie L Skala, M.D., Aaron M Udager, M.D., Ph.D., Ulka Vaishampayan, MBBS, Rahul Mannan, M.D., Saravana M Dhanasekaran, Ph.D., Arul M Chinnaiyan, M.D., Ph.D., Bryan L Betz, Ph.D., Noah Brown, M.D.

Paper cited: “Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations,” American Journal of Clinical Pathology. DOI: 10.1093/ajcp/aqad089


More Articles About: All Research Topics Cancer Research Cancer and Genetics Kidney Disease Kidney Cancer
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories yellow pills spilling out of bottle
Health Lab
Study sheds light on why some prostate tumors are resistant to treatment
A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment. 
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Is it time to let go of "holding it"?
Did you know that fighting the urge to pee could rewire your brain, and not in a good way? A neuro-urologist and pelvic reconstruction specialist explains. Read the full story on the Health Lab website.
History map
News Release
From the Diag to the world: 175 years of U-M medical history
An interactive map and article that trace the history of Michigan Medicine
pink cells up close
Health Lab
Research links iron-mediated cell death and inflammatory bowel disease
New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.
two foxes on grass
Health Lab
Study reveals mechanisms behind common mutation and prostate cancer
A study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.
man showing device in his hand smiling with blue gloves on
Health Lab
First-of-its-kind therapeutic device saves child in septic shock with multiorgan failure
The selective cytopheretic device, created by scientists and doctors at Michigan Medicine, is a first-in-class autologous immune cell directed therapy and successfully treated a young patient in septic shock and multiorgan failure.